Results 101 to 110 of about 8,760 (175)

Characteristics and treatment of pyoderma gangrenosum in inflammatory bowel disease

open access: yes, 2013
Background Pyoderma gangrenosum is a serious cutaneous complication seen in approximately 1 % of patients with inflammatory bowel disease (IBD). Oral corticosteroids are the mainstay treatment, although the evidence supporting their use is weak.
Garcia-Sanchez, V.   +16 more
core   +1 more source

Therapy Insight: pyoderma gangrenosum-old disease, new management.

open access: yes, 2005
Well-designed studies that help guide physicians to apply the optimal therapeutic strategy for the management of pyoderma gangrenosum are lacking in the literature. A multidisciplinary approach is paramount for the effective management of this condition,
Jewell, DP   +5 more
core   +1 more source

Issue Information

open access: yes
JEADV Clinical Practice, Volume 5, Issue 2, Page 351-356, June 2026.
wiley   +1 more source

PYODERMA GANGRENOSUM

open access: yes, 2015
Περιγράφεται περίπτωση γαγγραινώδους πυοδέρματος, μιας δερματοπάθειας που χαρακτηρίζεται από χρόνια υποτροπιάζοντα έλκη με συνύπαρξη βλαβών αγγειίτιδας.
ΑΝΔΡΟΥΛΑΚΗΣ, Ι.   +2 more
core  

Superficial Granulomatous Pyoderma

open access: yesIndian Journal of Dermatology, 2003
Superficial granulomatous pyoderma is an uncommon, benign, superficial variant of pyoderma gangrenosum, having granulomatous histological features and no systemic association. We describe 6 Indian patients with superficial granulomatous pyoderma.
Sarkar Rashmi   +3 more
doaj  

A challenging diagnosis: case report of extensive pyoderma gangrenosum at multiple sites

open access: yes, 2014
Mingwei J Ye,1,2 Joshua Mingsheng Ye,2 Leonard Wu,3 Cameron P Keating,4 Wai-Ting Choi41Department of Dermatology, Western Hospital, Footscray, VIC, Australia; 2University of Melbourne, Department of Medicine, Dentistry and Health Sciences, Parkville, VIC,
Ye JM, Wu L, Ye MJ, Keating CP, Choi WT
core  

Pyoderma Gangrenosum of the Eyelid: A Challenging Case. [PDF]

open access: yesAm J Case Rep
AlAbdullah ZA   +3 more
europepmc   +1 more source

Bimekizumab for recalcitrant pyoderma gangrenosum. [PDF]

open access: yesJAAD Case Rep
Tolete C   +3 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy